News 21 nov 2023 Interview with HYCON GmbH HYCON is a Swiss-based company of consultants and engineers focusing on renewable energy, WASH (water, sanitation and hygiene), land management, ...
News 13 déc 2022 New Empa method indicates virus death in face masks With the help of a method developed at the Swiss Federal Laboratories for Materials Science and Technology (Empa), researchers can compare which ...
News 23 mai 2023 University of Basel and RocketVax present new COVID vaccine Researchers from the University of Basel have developed a new concept for a COVID vaccine in collaboration with the biotech start-up RocketVax. I...
Aktuell 23 mai 2023 Universität Basel und RocketVax stellen neuen COVID-Impfstoff vor Forschende der Universität Basel haben mit dem Biotech-Start-up RocketVax ein neues Konzept für einen Corona-Impfstoff entwickelt. Er beruht auf ...
Aktuell 18 mar 2020 Trump lobt Coronavirus-Test von Roche Die US-amerikanische Zulassungsbehörde hat einen Test der Basler Pharmafirma Roche für das Virus SARS-CoV 2 zugelassen. Durch die Arbeit von Roch...
News 18 nov 2020 Lonza manufactures coronavirus vaccine for Moderna Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of the year. Moderna published the initial results...
News 05 juin 2020 Not just coronavirus: An overview of important export topics from recent weeks Alongside COVID-19, decrees have been made and decisions taken in other areas that are of relevance for international business: An overview of ke...
Novità 09 juin 2020 Non solo coronavirus: una panoramica sui più importanti temi delle ultime settimane legati alle esportazioni Oltre a quelle relative al COVID-19, sono state adottate ordinanze e decisioni anche in altre aree tematiche rilevanti per il commercio internazi...
News 19 oct 2020 Zurich remains attractive to investors despite coronavirus Venture capital investments have declined throughout Europe during the coronavirus crisis. However, a completely different picture emerges in rel...
News 16 sep 2020 Lonza set to manufacture coronavirus drug for Humanigen The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonz...
News 07 sep 2020 Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that simultaneously tests...
News 26 mar 2020 Reusable masks to fight coronavirus: a Swiss start-up has the solution Swoxid, a cleantech start-up spun from the Laboratory of Physics of Complex Matter at the Swiss Federal Institute of Technology in Lausanne, has ...
News 21 aoû 2020 Researchers develop novel approach against the coronavirus The Swiss National Science Foundation is funding a novel approach for a coronavirus vaccine. This approach developed by virologist Cornel Fraefel...
Aktuell 27 mai 2020 Celonic bekämpft Coronavirus mit Kooperation Die Basler Biopharmafirma Celonic Group hat eine Zusammenarbeit mit der amerikanischen Airway Therapeutics vereinbart. Gemeinsam wollen beiden Fi...
News 18 sep 2020 Crypto Valley thriving despite coronavirus crisis The number of companies in Switzerland and Liechtenstein working on blockchain technologies increased to 919 in the first half of the year. They ...
Aktuell 30 mar 2020 Universität Basel sucht Wirkstoff gegen Coronavirus Die Universität Basel setzt bei ihrer Suche nach einem Wirkstoff gegen das Coronavirus auf computergestützte Methoden. So sind bereits knapp 700 ...
